A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol

The GIMEMA LAL1509 protocol, designed for adult (≥18-60 years) de novo Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) patients, was based on dasatinib plus steroids induction - with central nervous system prophylaxis - followed by dasatinib alone in patients in complete mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiaretti, Sabina, Ansuinelli, Michela, Vitale, Antonella, Elia, Loredana, Matarazzo, Mabel, Piciocchi, Alfonso, Fazi, Paola, Di Raimondo, Francesco, Santoro, Lidia, Fabbiano, Francesco, Califano, Catello, Martinelli, Giovanni, Ronco, Francesca, Ferrara, Felicetto, Cascavilla, Nicola, Bigazzi, Catia, Tedeschi, Alessandra, Sica, Simona, Di Renzo, Nicola, Melpignano, Angela, Beltrami, Germana, Vignetti, Marco, Foà, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252956/
https://www.ncbi.nlm.nih.gov/pubmed/33538150
http://dx.doi.org/10.3324/haematol.2020.260935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252956/
https://www.ncbi.nlm.nih.gov/pubmed/33538150
http://dx.doi.org/10.3324/haematol.2020.260935

Ejemplares similares